Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemia
published in: Endocrine
date of publication: 2016-04-01
main subject: dyslipidemias, metabolic syndrome, atherosclerosis, insulin resistance
Cites articles 115
- 2015-07-03
- 2015-06-01
- 2014-08-13
Date
Title
Article - wd:Q38796312